Mirjeta Berisha

4PUBLICATIONS
25CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 06, 2024
Lautropia mirabilis sepsis in immunodeficiency: first report and genomic features.

Svea Genseke, Mirjeta Berisha, Aljoscha Teerstegen

|Jan 02, 2024
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.

Vanja Zeremski, Louisa Adolph, Sina Beer

|Sep 14, 2023
Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.

Daniel Teschner, Mirjeta Berisha, Jens Panse

|May 15, 2023
Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies-a retrospective single-centre analysis of 200 cases.

Daniel Geßner, Mirjeta Berisha, Torben Esser

Pageof 1

Frequent Collaborators

3 joint publications

Enrico Schalk

2 joint publications

Jens Panse

2 joint publications

Martin Schmidt-Hieber

1 joint publications

Daniel Teschner